Abstract
Premature hair graying (PHG) has been associated with autoimmune disease (AD) including premature ovarian, thyroid, and adrenal failure and reduced bone mineral density at menopause, suggesting that these latter women have earlier reduced ovarian reserve. This study was designed to determine whether women undergoing treatment for unexplained infertility with PHG and/or AD and normal ovarian reserve at baseline, CD3 FSH < 15 mIU/ml and estradiol < 100 pg/ml, have impaired treatment markers of ovarian reserve.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
